Opus Genetics is trading 5.6% up at $3.87, with no new August 11, 2026 company announcement or explicit news-to-price link identified.
- The latest material update, released August 6, reported Q2 results, an expected cash runway into 2029, completed LCA5 enrollment, and September BEST1 data, but did not connect those developments to the current move.
- Reported volume is 154.64K versus 910.11K average volume, indicating lighter-than-normal trading activity.